Pages that link to "Q28542490"

The following pages link to Azvudine, a novel nucleoside reverse transcriptase inhibitor showed good drug combination features and better inhibition on drug-resistant strains than lamivudine in vitro (Q28542490):

Displaying 9 items.

• Synthesis and Anti-HIV-1 Activity Evaluation for Novel 3a,6a-Dihydro-1H-pyrrolo[3,4-c]pyrazole-4,6-dione Derivatives. (Q38746848) (← links)
• MK-8591 (4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine) Exhibits Potent Activity against HIV-2 Isolates and Drug-Resistant HIV-2 Mutants in Culture. (Q38755690) (← links)
• Anti-HIV Activities and Mechanism of 12-O-Tricosanoylphorbol-20-acetate, a Novel Phorbol Ester from Ostodes katharinae. (Q40051104) (← links)
• SJP-L-5 inhibits HIV-1 polypurine tract primed plus-strand DNA elongation, indicating viral DNA synthesis initiation at multiple sites under drug pressure (Q50129893) (← links)
• HIV Reverse Transcriptase and Protease Genes Variability Can Be a Biomarker Associated with HIV and Hepatitis B or C Coinfection. (Q55020251) (← links)
• The pyrimidine analog FNC potently inhibits the replication of multiple enteroviruses (Q89790315) (← links)
• Synthesis and biological evaluation of a series of 2-(((5-akly/aryl-1H-pyrazol-3-yl)methyl)thio)-5-alkyl-6-(cyclohexylmethyl)-pyrimidin-4(3H)-ones as potential HIV-1 inhibitors (Q90094399) (← links)
• Review of trials currently testing treatment and prevention of COVID-19 (Q95627597) (← links)
• Immune-mediated approaches against COVID-19 (Q97530822) (← links)